PCNA-I1

TargetMol
Product Code: TAR-T8955
Supplier: TargetMol
CodeSizePrice
TAR-T8955-1mg1mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8955-5mg5mg£269.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8955-1mL1 mL * 10 mM (in DMSO)£283.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8955-10mg10mg£369.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8955-25mg25mg£576.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8955-50mg50mg£790.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8955-100mg100mg£1,050.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8955-500mg500mg£2,038.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
PCNA-I1 is an inhibitor targeting PCNA chromatin association in prostate cancer.
CAS:
444930-42-1
Formula:
C17H14N2O2S
Molecular Weight:
310.37
Purity:
0.9764
SMILES:
Cc1ccsc1C(=O)NN=Cc1ccc2ccccc2c1O

References

Dillehay K L , Seibel W L , Zhao D , et al. Target validation and structure?activity analysis of a series of novel PCNA inhibitors[J]. Pharmacology Research & Perspectives, 2015, 3(2). Dillehay K L , Lu S , Dong Z . Antitumor Effects of a Novel Small Molecule Targeting PCNA Chromatin Association in Prostate Cancer[J]. Molecular Cancer Therapeutics, 2014, 13(12):2817-26.